NPY also inhibited tumor cell growth and invasion in cholangiocarcinoma; both effects were counteracted with antibodies against NPY [113], and via Y1R, NPY blocked tumor cell growth in hepatocellular carcinoma [159]. The gene discussed is NPY; the disease is cholangiocarcinoma.